drugset / Trial / NCT01054976

The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's Disease

NCT01054976

Phase 4 Completed 99 enrolled Janssen Korea, Ltd., Korea
NaSingle-groupOpen-labelTreatment

Summary

This study will examine whether the administration of galantamine is effective for improvement of attention and more effective for patients with serious disturbance of attention by administering galantamine to patients with Alzheimer's dementia and performing an attention test on baseline, week 4 and 12.

Timeline

Start
2006-10
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Galantamine Small molecule 16 mg Oral

Indications